Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A Novel Defined Super-Enhancer Associated Gene Signature to Predict Prognosis in Patients With Diffuse Large B-Cell Lymphoma

14 Jun 2022

Abstract excerpt

Background: Diffuse large B-cell lymphoma (DLBCL) is a genetically heterogeneous disease that can have profound differences in survival outcomes. A variety of powerful prognostic factors and models have been constructed; however, the development of more accurate prognosis prediction and targeted treatment for DLBCL still faces challenges. An explosion of research on super-enhancer (SE)–associated genes provide...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related gene regulation
Share to Lymphoma Diagnosis and Treatment
Share to Ubiquitin and proteasome pathways

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35774514
DOI: 10.3389/fgene.2022.827840

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A Novel Defined Super-Enhancer Associated Gene Signature to Predict Prognosis in Patients With Diffuse Large B-Cell LymphomaPMID 35774514Read ↗

Whole Transcriptome Data Analysis Reveals Prognostic Signature Genes for Overall Survival Prediction in Diffuse Large B Cell LymphomaSemantic proximity Read ↗

Large-scale transcriptome data analysis reveals prognostic signature genes for overall survival prediction in diffuse large B cell lymphomaSemantic proximity Read ↗

Ferroptosis-Related Gene Signature: A New Method for Personalized Risk Assessment in Patients with Diffuse Large B-Cell LymphomaSemantic proximity Read ↗

Super-enhancer associated nine-gene prognostic score model for prediction of survival in chronic lymphoic leukemia patientsSemantic proximity Read ↗

The Identification and Analysis of a Novel Model Based on Ferroptosis-Related Genes for Predicting the Prognosis of Diffuse Large B-Cell LymphomasSemantic proximity Read ↗

Prognostic mutation signature would serve as a potential prognostic predictor in patients with diffuse large B-cell lymphoma.Semantic proximity Read ↗

Gene expression-based risk score in diffuse large B-cell lymphoma.Semantic proximity Read ↗

Predictive biomarkers and molecular subtypes in DLBCL: insights from PCD gene expression and machine learningSemantic proximity Read ↗

Improved Personalized Survival Prediction of Patients With Diffuse Large B-cell Lymphoma Using Gene Expression ProfilingSemantic proximity Read ↗

A novel super-enhancer-related gene signature predicts prognosis and immune microenvironment for breast cancerSemantic proximity Read ↗

The Identification and Analysis of a Novel Model Based on Ferroptosis-Related Genes for Predicting the Prognosis of Diffuse Large B-Cell LymphomasSemantic proximity Read ↗

Genetic and transcriptomic analyses of diffuse large B-cell lymphoma patients with poor outcomes within two years of diagnosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.